CRONOS GROUP INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CRONOS GROUP INC. (CRON) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.59 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.59M shares, a 70.98% decline year-over-year.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.29M shares, a 92.95% decline year-over-year.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 18.06M shares, a 19.89% increase year-over-year.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 15.81M shares, a 45.04% decline year-over-year.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 18.98M shares, a 11.19% increase from fiscal 2024.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 17.07M shares, a 32.86% decline from fiscal 2023.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 25.43M shares, a 77.42% decline from fiscal 2022.
- CRONOS GROUP INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 112.61M shares, a 10.05% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.59M shares 10-Q · filed 2026-08-06 | 2.94M shares 10-Q · filed 2026-08-06 | |||||
| 2026-03-31 | 1.29M shares 10-Q · filed 2026-05-11 | ||||||
| 2025-12-31 | 18.98M shares 10-K · filed 2026-02-26 | ||||||
| 2025-09-30 | 18.06M shares 10-Q · filed 2025-11-06 | 19.35M shares 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | 15.81M shares 10-Q · filed 2026-08-06 | 19.05M shares 10-Q · filed 2026-08-06 | 29.43M shares 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | 18.27M shares 10-Q · filed 2026-05-11 | ||||||
| 2024-12-31 | 17.07M shares 10-K · filed 2026-02-26 | ||||||
| 2024-09-30 | 15.07M shares 10-Q · filed 2025-11-06 | 20.93M shares 10-Q · filed 2025-11-06 | |||||
| 2024-06-30 | 28.77M shares 10-Q · filed 2025-08-07 | 19.43M shares 10-Q · filed 2024-08-08 | 19.05M shares 10-Q · filed 2025-08-07 | 22.01M shares 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 24.58M shares 10-Q · filed 2025-05-08 | ||||||
| 2023-12-31 | 25.43M shares 10-K · filed 2026-02-26 | ||||||
| 2023-09-30 | 23.34M shares 10-Q · filed 2024-11-12 | 27.40M shares 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | 28.77M shares 10-Q · filed 2024-08-08 | 29.43M shares 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | 30.09M shares 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | 112.61M shares 10-K · filed 2025-02-27 | ||||||
| 2022-09-30 | 117.10M shares 10-Q · filed 2023-11-08 | 118.30M shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 119.59M shares 10-Q · filed 2023-08-08 | 118.91M shares 10-Q · filed 2023-08-08 | |||||
| 2022-03-31 | 118.22M shares 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | 125.20M shares 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | 118.26M shares 10-Q · filed 2022-11-07 | 127.14M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 120.49M shares 10-Q · filed 2022-08-09 | 116.86M shares 10-Q · filed 2021-08-06 | 128.37M shares 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | 136.95M shares 10-Q · filed 2022-05-10 | ||||||
| 2020-12-31 | 151.34M shares 10-K · filed 2023-02-28 | ||||||
| 2020-09-30 | 134.39M shares 10-Q · filed 2022-02-18 | 133.37M shares 10-Q · filed 2020-11-05 | 134.50M shares 10-Q · filed 2022-02-18 | 132.92M shares 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 162.09M shares 10-Q/A · filed 2022-02-18 | 162.16M shares 10-Q/A · filed 2022-02-18 | |||||
| 2020-03-31 | 134.22M shares 10-Q · filed 2021-05-07 | 132.98M shares 10-Q · filed 2020-05-08 | |||||
| 2019-12-31 | 131.87M shares 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | 130.80M shares 10-Q · filed 2020-11-05 | 53.12M shares 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | 52.96M shares 10-Q · filed 2020-08-06 | 52.96M shares 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | 54.41M shares 10-Q · filed 2020-05-08 | ||||||
| 2018-12-31 | 38.36M shares 10-K · filed 2021-02-26 | ||||||
| 2017-12-31 | 0.00 shares 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |